SG Americas Securities’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$348K	Sell	9,571 -12,218	-56%	-$546K	﹤0.01%	2379
2025 Q4	$1.01M	Sell	21,789 -10,482	-32%	-$467K	﹤0.01%	2006
2025 Q3	$1.34M	Buy	32,271 +11,989	+59%	+$383K	﹤0.01%	1208
2025 Q2	$583K	Sell	20,282 -501,984	-96%	-$15.5M	﹤0.01%	1564
2025 Q1	$17.5M	Sell	522,266 -20,180	-4%	-$754K	0.06%	223
2024 Q4	$27.7M	Buy	542,446 +529,483	+4,085%	+$29.6M	0.11%	96
2024 Q3	$662K	Sell	12,963 -66,088	-84%	-$3.41M	﹤0.01%	1443
2024 Q2	$3.54M	Buy	79,051 +73,084	+1,225%	+$3.38M	0.02%	701
2024 Q1	$279K	Buy	+5,967	New	+$233K	﹤0.01%	1737
2023 Q2	–	Sell	-26,166	Closed	-$420K	–	2454
2023 Q1	$420K	Buy	26,166 +16,399	+168%	+$303K	﹤0.01%	1853
2022 Q4	$179K	Sell	9,767 -5,559	-36%	-$98K	﹤0.01%	2279
2022 Q3	$301K	Sell	15,326 -10,066	-40%	-$205K	﹤0.01%	1989
2022 Q2	$474K	Buy	+25,392	New	+$507K	0.01%	2004
2022 Q1	–	Sell	-6,366	Closed	-$181K	–	3042
2021 Q4	$181K	Sell	6,366 -12,901	-67%	-$318K	﹤0.01%	2725
2021 Q3	$406K	Buy	+19,267	New	+$403K	﹤0.01%	2687
2020 Q3	–	Sell	-14,802	Closed	-$259K	–	2838
2020 Q2	$259K	Buy	+14,802	New	+$252K	﹤0.01%	2629